2:26-cv-01633 TAKEDA PHARMACEUTICAL COMPANY LIMITED v. QILU PHARMACEUTICAL (HAINAN) CO., LTD.
Case Summary
This civil case involves a corporate disclosure statement filed by Takeda Pharmaceutical Company Limited against Qilu Pharmaceutical (Hainan) Co., Ltd. The statement addresses regulatory compliance, corporate governance, and potential liabilities arising from pharmaceutical practices.
Stage
Active litigation
Timeline
2 events
Coverage
2 articles
Sources
1
Key Issues
- • Corporate disclosure statement
- • Regulatory compliance
- • Pharmaceutical practices
update What Changed This Week
Case Timeline
2 events2:26-cv-01633 Tipavan Krongchana et al v. Metropolitan Life Insuance Company et al
Amended Complaint/Petition ( 19
2:26-cv-01633 TAKEDA PHARMACEUTICAL COMPANY LIMITED v. QILU PHARMACEUTICAL (HAINAN) CO., LTD.
In a corporate disclosure statement, Takeda Pharmaceutical Company Limited filed a document against Qilu Pharmaceutical (Hainan) Co., Ltd., outlining their legal dispute and the reasons behind it.
Coverage Timeline
Press Coverage
2:26-cv-01633 Tipavan Krongchana et al v. Metropolitan Life Insuance Company et al
Amended Complaint/Petition ( 19
2:26-cv-01633 TAKEDA PHARMACEUTICAL COMPANY LIMITED v. QILU PHARMACEUTICAL (HAINAN) CO., LTD.
Corporate Disclosure Statement (aty) ( 10